The Use of Next-Generation Sequencing to Assist in the Diagnosis of Atypical Vasculitis

David A Chetrit1, Thanda Aung2, Quen J Cheng3

  • 1Division of Rheumatology, Carolina Health Specialists, Myrtle Beach, USA.

Cureus
|December 10, 2024
PubMed

Insights

A challenging vasculitis case was diagnosed using next-generation sequencing (NGS) which identified Prevotella melaninogenica. This advanced diagnostic approach, combined with tailored treatment, led to a favorable outcome in atypical vasculitis.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Rheumatology

Background:

  • Vasculitis diagnosis is complex, particularly with multi-systemic involvement and atypical presentations.
  • Standard diagnostic methods often fail to identify the underlying etiology in challenging vasculitis cases.

Observation:

  • A 58-year-old woman presented with neurological deficits following a dental procedure.
  • She exhibited multi-focal ischemic infarctions affecting intracranial and intra-abdominal blood vessels.
  • Initial investigations for common autoimmune and infectious causes were inconclusive.

Findings:

  • Next-generation sequencing (NGS) of cell-free DNA identified Prevotella melaninogenica as the infectious trigger.
  • This pathogen was linked to the patient's vasculitis and multi-focal infarctions.
  • A combination therapy including antimicrobials, steroids, and plasmapheresis resulted in a favorable outcome.

Implications:

  • NGS offers a powerful tool for diagnosing atypical vasculitis with elusive infectious triggers.
  • Early and accurate diagnosis through advanced sequencing can guide effective, multi-modal treatment strategies.
  • This case highlights the potential of integrating molecular diagnostics into the management of complex vasculitis.